Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study - Li, Jun; Peng, Liying; Wu, Lijun; Ding, Yufang; Duan, Xinwang; Xu, Jian; Wei, Wei; Chen, Zhen; Zhao, Cheng; Yang, Min; Jiang, Nan; Zhang, Shangzhu; et al. (Arthritis research & therapy, 2024)
Keywords: Antibodies; Antiphospholipid antibodies; Blood platelets; Bone marrow; Care and treatment; Cohort analysis; Complications and side effects; Development and progression; Hematology; Laboratories; Leukemia; Lupus; Medical prognosis; Prognosis; Rheumatology; Risk factors; Severity; Systemic Lupus Erythematosus; Testing; Thrombocytopenia; China; United States--US; Germany; Systemic Lupus Erythematosus; Thrombocytopenia; Severity; Prognosis; Antiphospholipid antibodies